
Jeevan Scientific Technology Ltd: Valuation Shift Signals Renewed Price Attractiveness
2026-06-02 08:01:09Jeevan Scientific Technology Ltd, a micro-cap player in the healthcare services sector, has recently experienced a notable shift in its valuation parameters, moving from a risky to a fair valuation grade. This article analyses the changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors amid recent market volatility.
Read full news article
Jeevan Scientific Technology Ltd Reports Exceptional Quarterly Growth, Upgrades Financial Trend
2026-06-01 08:00:20Jeevan Scientific Technology Ltd has delivered a remarkable quarterly performance for March 2026, signalling a significant turnaround in its financial trajectory. The company’s latest results reveal robust revenue growth, substantial margin expansion, and a marked improvement in profitability, positioning it favourably within the healthcare services sector despite broader market headwinds.
Read full news article
Jeevan Scientific Technology Ltd is Rated Hold
2026-05-31 10:10:18Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleAre Jeevan Scientific Technology Ltd latest results good or bad?
2026-05-30 19:46:08Jeevan Scientific Technology Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant revenue growth alongside persistent challenges in profitability. The company reported consolidated net sales of ₹21.29 crores, marking a remarkable year-on-year growth of 111.63%. This surge in revenue indicates strong client traction and suggests that the company is successfully securing new contracts in its clinical research and data management services. However, despite this topline performance, the company's profitability metrics reveal underlying concerns. The consolidated net profit stood at ₹1.61 crores, reflecting a substantial year-on-year increase of 223.85%. Yet, the operating margin has compressed to 20.24%, down from 27.43% in the previous quarter, indicating rising cost pressures that could undermine the sustainability of this revenue growth. The profit after tax (PAT...
Read full news article
Jeevan Scientific Q4 FY26: Stellar Turnaround Masks Underlying Volatility Concerns
2026-05-29 20:47:18Jeevan Scientific Technology Ltd., a micro-cap clinical research organisation, posted a consolidated net profit of ₹1.61 crores in Q4 FY26 (Mar'26), marking a 13.38% sequential improvement from ₹1.42 crores in Q3 FY26. However, this represents a sharp reversal from a loss of ₹1.30 crores in the same quarter last year, translating to a year-on-year decline of 223.85% when measured against the prior year's loss-making base.
Read full news articleWhen is the next results date for Jeevan Scientific Technology Ltd?
2026-05-22 23:19:15The next results date for Jeevan Scientific Technology Ltd is scheduled for 29 May 2026....
Read full news article
Jeevan Scientific Technology Ltd is Rated Sell
2026-05-20 10:10:03Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of its performance and outlook.
Read full news article
Jeevan Scientific Technology Ltd is Rated Sell
2026-05-09 10:10:03Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Jeevan Scientific Technology Ltd is Rated Sell
2026-05-09 10:10:03Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleCompliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the Financial year ended 31st March2026 as per Regulation 24 A of SEBI (Listing and Disclosure Requirements) Regulations 2015(Listing Regulations)
Audited Financial Results For The Quarter And Year Ended 31.03.2026
29-May-2026 | Source : BSEAudited financial results for the quarter and year ended 31.03.2026
Announcement under Regulation 30 (LODR)-Change in Management
29-May-2026 | Source : BSEAppointment of M/s. KP & Associates Chartered Accountants as Internal Auditors of the Company for the FY 2026-27
Corporate Actions
No Upcoming Board Meetings
Jeevan Scientific Technology Ltd has declared 12% dividend, ex-date: 21 Sep 22
No Splits history available
No Bonus history available
No Rights history available






